Moorhead John Hunnewell Jr
Director
Award
Calculated transaction value
$0
1,760 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 5, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Femasys Inc
FEMY
Transactions reported in official disclosures
21 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Moorhead John Hunnewell Jr Director | Nov 5, 2026 6-day lag | Award Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Eichenbaum Kenneth D. Director | Aug 11, 2026 48-day lag | Award Jun 24, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Uzialko Edward R Director | Aug 11, 2026 48-day lag | Award Jun 24, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Milnes Alistair Director | Aug 11, 2026 48-day lag | Award Jun 24, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Larsen Charles Director | Aug 11, 2026 48-day lag | Award Jun 24, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Mifek Jeffrey Gerald Chief Clinical-medical Affairs | Aug 11, 2026 4-day lag | Buy Aug 7, 2026 | $10K Filed shares x price | SEC Form 4 View filing | |
| Mifek Jeffrey Gerald Chief Clinical-medical Affairs | Aug 11, 2026 4-day lag | Award Aug 7, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Mifek Jeffrey Gerald Chief Clinical-medical Affairs | Aug 11, 2026 4-day lag | Award Aug 7, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Mifek Jeffrey Gerald Chief Clinical-medical Affairs | Aug 11, 2026 36-day lag | Award Jul 6, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Sipos Jeremy Alexander Chief Technology Officer | Aug 11, 2026 4-day lag | Buy Aug 7, 2026 | $10K Filed shares x price | SEC Form 4 View filing | |
| Sipos Jeremy Alexander Chief Technology Officer | Aug 11, 2026 4-day lag | Award Aug 7, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Sipos Jeremy Alexander Chief Technology Officer | Aug 11, 2026 4-day lag | Award Aug 7, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Canning John Charles Chief Operating Officer | Aug 11, 2026 4-day lag | Award Aug 7, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Canning John Charles Chief Operating Officer | Aug 11, 2026 4-day lag | Award Aug 7, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Canning John Charles Chief Operating Officer | Aug 11, 2026 4-day lag | Buy Aug 7, 2026 | $14K Filed shares x price | SEC Form 4 View filing | |
| Elefant Dov Chief Financial Officer | Aug 11, 2026 4-day lag | Award Aug 7, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Elefant Dov Chief Financial Officer | Aug 11, 2026 4-day lag | Award Aug 7, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Elefant Dov Chief Financial Officer | Aug 11, 2026 4-day lag | Buy Aug 7, 2026 | $50K Filed shares x price | SEC Form 4 View filing | |
| Lee-sepsick Kathy Chief Executive Officer | Aug 11, 2026 4-day lag | Buy Aug 7, 2026 | $50K Filed shares x price | SEC Form 4 View filing | |
| Lee-sepsick Kathy Chief Executive Officer | Aug 11, 2026 4-day lag | Award Aug 7, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Lee-sepsick Kathy Chief Executive Officer | Aug 11, 2026 4-day lag | Award Aug 7, 2026 | Not reported Reported range | SEC Form 4 View filing |
Eichenbaum Kenneth D.
Director
Award
Calculated transaction value
$0
880 shares @ $0
Traded
Jun 24, 2026
Filed
Aug 11, 2026
Uzialko Edward R
Director
Award
Calculated transaction value
$0
880 shares @ $0
Traded
Jun 24, 2026
Filed
Aug 11, 2026
Milnes Alistair
Director
Award
Calculated transaction value
$0
880 shares @ $0
Traded
Jun 24, 2026
Filed
Aug 11, 2026
Larsen Charles
Director
Award
Calculated transaction value
$0
880 shares @ $0
Traded
Jun 24, 2026
Filed
Aug 11, 2026
Mifek Jeffrey Gerald
Chief Clinical-medical Affairs
Buy
Calculated transaction value
$10K
3,125 shares @ $3.2
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Mifek Jeffrey Gerald
Chief Clinical-medical Affairs
Award
Reported value range
Not reported
3,125 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Mifek Jeffrey Gerald
Chief Clinical-medical Affairs
Award
Reported value range
Not reported
3,125 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Mifek Jeffrey Gerald
Chief Clinical-medical Affairs
Award
Calculated transaction value
$0
6,250 shares @ $0
Traded
Jul 6, 2026
Filed
Aug 11, 2026
Sipos Jeremy Alexander
Chief Technology Officer
Buy
Calculated transaction value
$10K
3,125 shares @ $3.2
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Sipos Jeremy Alexander
Chief Technology Officer
Award
Reported value range
Not reported
3,125 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Sipos Jeremy Alexander
Chief Technology Officer
Award
Reported value range
Not reported
3,125 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Canning John Charles
Chief Operating Officer
Award
Reported value range
Not reported
4,375 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Canning John Charles
Chief Operating Officer
Award
Reported value range
Not reported
4,375 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Canning John Charles
Chief Operating Officer
Buy
Calculated transaction value
$14K
4,375 shares @ $3.2
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Elefant Dov
Chief Financial Officer
Award
Reported value range
Not reported
15,625 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Elefant Dov
Chief Financial Officer
Award
Reported value range
Not reported
15,625 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Elefant Dov
Chief Financial Officer
Buy
Calculated transaction value
$50K
15,625 shares @ $3.2
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Lee-sepsick Kathy
Chief Executive Officer
Buy
Calculated transaction value
$50K
15,625 shares @ $3.2
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Lee-sepsick Kathy
Chief Executive Officer
Award
Reported value range
Not reported
15,625 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Lee-sepsick Kathy
Chief Executive Officer
Award
Reported value range
Not reported
15,625 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026